Dickkopf-3 as a new potential marker for neoangiogenesis in colorectal cancer: Expression in cancer tissue and adjacent non-cancerous tissue

Disease Markers

Volumn 24, Issue 2, 2008, Pages 101-109

  Zitt, Matthias ^a   Untergasser, Gerold ^a   Amberger, Albert ^b   Moser, Patrizia ^a   Stadlmann, Sylvia ^c   Zitt, Marion ^b   Müller, Hannes M ^a   Mühlmann, Gilbert ^a   Perathoner, Alexander ^a   Margreiter, Raimund ^a,b   Gunsilius, Eberhard ^a   Öfner, Dietmar ^a  

^a INNSBRUCK MEDICAL UNIVERSITY   (Austria)

^b TYROLEAN CANCER RESEARCH INSTITUTE   (Austria)

^c UNIVERSITY HOSPITAL BASEL   (Switzerland)

Author keywords

Adjacent tissue; Colorectal cancer; Dickkopf 3; Neoangiogenesis; Tissue microarrays

Indexed keywords

CD31 ANTIGEN; CELL PROTEIN; PROTEIN DICKKOPF 3; THROMBOSPONDIN 2; UNCLASSIFIED DRUG; VASCULOTROPIN;

ADULT; AGED; ANGIOGENESIS; ARTICLE; COLORECTAL CANCER; CONTROLLED STUDY; DISEASE MARKER; ENDOTHELIUM CELL; FEMALE; GENE EXPRESSION REGULATION; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; MICROVASCULATURE; PRIORITY JOURNAL; PROTEIN STRUCTURE; STRUCTURE ANALYSIS; TISSUE DISTRIBUTION;

EID: 38349133630     PISSN: 02780240     EISSN: None     Source Type: Journal    
DOI: 10.1155/2008/160907     Document Type: Article

References (33)

1. E. Sperti, R. Faggiuolo, A. Gerbino et al., Outcome of Metastatic Colorectal Cancer: Analysis of a Consecutive Series of 229 Patients. The Impact of a Multidisciplinary Approach, Dis Colon Rectum (2006), Epub ahead of print.
2. G.B. Secco, R. Fardelli, D. Gianquinto et al., Efficacy and cost of risk-adapted follow-up in patients after colorectal cancer surgery: a prospective, randomized and controlled trial, Eur J Surg Oncol 28 (2002), 418-423.
3. M. Zitt, G. M̈uhlmann, H. Weiss et al., Assessment of risk-independent follow-up to detect asymptomatic recurrence after curative resection of colorectal cancer, Langenbecks Arch Surg 391 (2006), 369-375.
4. J. Folkman, Tumor angiogenesis: therapeutic implications, N Engl J Med 285 (1971), 1182-1186.
5. D. Hanahan and J. Folkman, Patterns of emerging mechanisms of the angiogenic switch during tumorigenesis, Cell 86 (1996), 353-364.
6. R. Poon Tung-Ping, Fan Sheung-Tat and J. Wong, Clinical significance of angiogenesis in gastrointestinal cancers, Ann Surg 238 (2003), 9-28.
7. P. Carmeliet and R.K. Jain, Angiogenesis in cancer and other diseases, Nature 407 (2000), 249-257.
8. B. St. Croix, C. Rago, V. Velculescu et al., Genes expressed in human tumor endothelium, Science 289 (2000), 1197-1202.
9. V.E. Krupnik, J.D. Sharp, C. Jiang et al., Functional and structural diversity of the human Dickkopf gene family, Gene 238 (1999), 301-313.
10. C. Niehrs, Function and biological roles of the Dickkopf family of WNT modulators, Oncogene 25 (2006), 7469-7481.
11. B. Mao, W. Wu, G. Davidson et al., Kremen proteins are Dickkopf receptors that regulate WNT/beta-catenin signalling, Nature 417 (2002), 664-667.
12. T. Tsuji, M. Miyazaki, M. Sakaguchi, Y. Inoue and M. Namba, A REIC gene shows down-regulation in human immortalized cells and human tumor-derived cell lines, Biochem Biophys Res Commun 268 (2000), 20-24.
13. K. Kobayashi, M. Ouchida, T. Tsuji et al., Reduced expression of the REIC/Dkk-3 gene by promoter-hypermethylation in human tumor cells, Gene 282 (2002), 151-158.
14. I. Nozaki, T. Tsuji, O. Iijima et al., Reduced expression of REIC/Dkk-3 gene in non-small cell lung cancer, Int J Oncol 19 (2001), 117-121.
15. K.Kurose, M. Sakaguchi, Y. Nasu et al., Decreased expression of REIC/Dkk-3 in human renal clear cell carcinoma, J Urol 171 (2004), 1314-1318.
16. J. Roman-Gomez, A. Jimenez-Velasco, X. Agirre et al., Transcriptional silencing of the Dickkopfs-3 (Dkk-3) gene by CpG hypermethylation in acute lymphoblastic leukaemia, Br J Cancer 91 (2004), 707-713.
17. S.Y. Hsieh, P.S. Hsieh, C.T. Chiu and W.Y. Chen, Dickkopf-3/REIC functions as a suppressor gene of tumor growth, Oncogene 23 (2004), 9183-9189.
18. Y. Kawano, M. Kitaoka, Y. Hamada, M.M. Walker, J. Waxman and R.M. Kypta, Regulation of prostate cell growth and morphogenesis by Dickkopf-3, Oncogene 25 (2006), 6528-6537.
19. D. Lodygin, A. Epanchintsev, A. Menssen, J. Diebold and H. Hermeking, Functional epigenomics identifies genes frequently silenced in prostate cancer, Cancer Res 65 (2005), 4218-4227.
20. S. Kuphal, S. Lodermeyer, F. Bataille, M. Schuierer, B.H. Hoang and A.K. Bosserhoff, Expression of Dickkopf genes is strongly reduced in malignant melanoma, Oncogene 25 (2006), 5027-5036.
21. T. Byun, M. Karimi, J.L. Marsh, T. Milovanovic, F. Lin and R.F. Holcombe, Expression of secreted WNT antagonists in gastrointestinal tissues: potential role in stem cell homeostasis, J Clin Pathol 58 (2005), 515-519.
22. J. Denekamp, Angiogenesis, neovascular proliferation and vascular pathophysiology as targets for cancer therapy, Br J Radiol 66 (1993), 181-196.
23. P. Vaupel, F. Kallinowski and P. Okunieff, Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumours: a review, Cancer Res 49 (1989), 6449-6465.
24. M. Klagsbrun and P.A. D'Amore, Regulators of angiogenesis, Annu Rev Physiol 53 (1991), 217-239.
25. D. Zagzag, Angiogenic growth factors in neural angiogenesis and neoplasia, Am J Pathol 146 (1995), 293-309.
26. R.K. Jain, Molecular regulation of vessel maturation, Nat Med 9 (2003), 685-693.
27. D. Hanahan and R.A.Weinberg, The hallmarks of cancer, Cell 100 (2000), 57-70.
28. N. Bouck, V. Stellmach and S.C. Hsu, How tumors become angiogenic, Adv Cancer Res 69 (1996), 135-174.
29. D. Fukumura, R. Xavier and T. Sugiura, Tumor induction of VEGF promoter activity in stromal cells, Cell 94 (1998), 712-725.
30. Y. Sugiyama, B. Farrow, C. Murillo, J. Li, H. Watanabe, K. Sugiyama and M. Evers, Gastroenterology 128 (2005), 480-486.
31. K. Birkenkamp-Demtroder, L.L. Christensen, S.H. Olesen et al., Gene expression in colorectal cancer, Cancer Res 62 (2002), 4352-4363.
32. Y.M. Lin, Y. Furukawa, T. Tsunoda, C.T. Yue, K.C. Yang and Y. Nakamura, Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas, Oncogene 21 (2002), 4120-4128.
33. A. Giatromanolaki, E. Sivridis and M.I. Koukourakis, Angiogenesis in Colorectal Cancer: Prognostic and Therapeutic Implications, Am J Clin Oncol 29 (2006), 408-417.